HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 2 (2005), Issue 10 (October)

1. Constructing HIV-1 integrase tetramer and exploring influences of metal ions on forming integrase-DNA complex.
   Biochem Biophys Res Commun, 337(1): 313-9. [Abstract] [Full-text]
2. HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases.
   Biochem Biophys Res Commun, 336(4): 1214-20. [Abstract] [Full-text]
3. Molecular dynamics studies of the full-length integrase-DNA complex.
   Biochem Biophys Res Commun, 336(4): 1010-6. [Abstract] [Full-text]
4. Monitoring insulin-like growth factors in HIV infection and AIDS.
   Clin Chim Acta, 361(1): 30-53. [Abstract] [Full-text]
5. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells.
   Blood, 106(8): 2790-7. [Abstract] [Full-text]
6. Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay.
   J Immunol Methods, 305(2): 128-34. [Abstract] [Full-text]
7. Aetiology of sexually transmitted disease (STD) and comparison of STD syndromes and aetiological diagnosis in Taipei, Taiwan.
   Clin Microbiol Infect, 11(11): 914-8. [Abstract] [Full-text]
8. The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo.
   Virology, 341(2): 313-20. [Abstract] [Full-text]
9. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand.
   Virology, 341(2): 238-47. [Abstract] [Full-text]
10. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
    Virology, 341(2): 190-202. [Abstract] [Full-text]
11. RNA interference directed to CDK2 inhibits HIV-1 transcription.
    Virology, 341(2): 171-8. [Abstract] [Full-text]
12. Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis.
    Cell Death Differ, 12(11): 1417-28. [Abstract] [Full-text]
13. An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction.
    J Virol, 79(21): 13806-10. [Abstract] [Full-text]
14. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.
    J Virol, 79(21): 13735-46. [Abstract] [Full-text]
15. LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
    J Virol, 79(21): 13714-24. [Abstract] [Full-text]
16. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?
    J Virol, 79(21): 13579-86. [Abstract] [Full-text]
17. Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.
    J Virol, 79(21): 13572-8. [Abstract] [Full-text]
18. Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer.
    J Virol, 79(21): 13519-27. [Abstract] [Full-text]
19. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
    J Virol, 79(21): 13463-72. [Abstract] [Full-text]
20. Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
    J Virol, 79(21): 13338-49. [Abstract] [Full-text]
21. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    J Virol, 79(21): 13250-61. [Abstract] [Full-text]
22. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    J Virol, 79(21): 13239-49. [Abstract] [Full-text]
23. Length of human immunodeficiency virus disease and not immune status is a risk factor for development of anal carcinoma.
    Am J Surg, 190(5): 732-5. [Abstract] [Full-text]
24. Economic evaluation of HIV treatments: the I.CO.N.A. cohort study.
    Health Policy, 74(3): 304-13. [Abstract] [Full-text]
25. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Clin Exp Immunol, 142(2): 388-97. [Abstract] [Full-text]
26. Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection.
    Clin Exp Immunol, 142(2): 354-61. [Abstract] [Full-text]
27. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.
    Clin Exp Immunol, 142(2): 327-32. [Abstract] [Full-text]
28. Effects of donor and acceptor RNA structures on the mechanism of strand transfer by HIV-1 reverse transcriptase.
    J Mol Biol, 353(4): 772-87. [Abstract] [Full-text]
29. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.
    J Mol Biol, 353(5): 945-51. [Abstract] [Full-text]
30. The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis.
    Rev Med Virol, 15(6): 365-81. [Abstract] [Full-text]
31. Outcome of HIV infected children with culture confirmed tuberculosis.
    Arch Dis Child, 90(11): 1171-4. [Abstract] [Full-text]
32. Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.
    Glia, 52(4): 344-53. [Abstract] [Full-text]
33. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users.
    Health Place, 12(1): 79-85. [Abstract] [Full-text]
34. The impact of anemia on energy and physical functioning in individuals with AIDS.
    Arch Intern Med, 165(19): 2229-36. [Abstract] [Full-text]
35. Social networks, perceptions of risk, and changing attitudes towards HIV/AIDS: new evidence from a longitudinal study using fixed-effects analysis.
    Popul Stud (Camb), 59(3): 265-82. [Abstract] [Full-text]
36. Visualization of retrovirus budding with correlated light and electron microscopy.
    Proc Natl Acad Sci U S A, 102(43): 15453-8. [Abstract] [Full-text]
37. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.
    Proc Natl Acad Sci U S A, 102(43): 15647-52. [Abstract] [Full-text]
38. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV.
    Lancet Infect Dis, 5(11): 726-31. [Abstract] [Full-text]
39. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Cytokine Growth Factor Rev, 16(6): 659-77. [Abstract] [Full-text]
40. Targets for human encoded microRNAs in HIV genes.
    Biochem Biophys Res Commun, 337(4): 1214-8. [Abstract] [Full-text]
41. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    J Mol Biol, 354(1): 55-72. [Abstract] [Full-text]
42. HIV-1 Cis Enhancing Sequence (CES) enhances CTE-dependent Gag expression.
    Virology, 342(1): 111-8. [Abstract] [Full-text]
43. Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.
    Virology, 342(1): 1-12. [Abstract] [Full-text]
44. A -1 frameshift in the HIV-1 env gene is enhanced by arginine deficiency via a hungry codon mechanism.
    Mutat Res, 579(1): 125-32. [Abstract] [Full-text]
45. An HIV-1 encoded peptide mimics the DNA binding loop of NF-kappaB and binds thioredoxin with high affinity.
    Mutat Res, 579(1): 133-48. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.